AXGN vs BBNX Stock Comparison

AXGN currently leads BBNX in this stock comparison, with AIQ scores of 65 vs 54. The clearest difference is risk resilience, while BBNX has the stronger value profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 11 points
AXGN
Healthcare
vs
BBNX
Healthcare
AXGN
AxoGen, Inc.
Leads
Price
$56.95
Day move
+2.85%
AIQ Score
65/100
Best edge
Risk Resilience
Sector
Healthcare
BBNX
Beta Bionics, Inc.
Price
$14.33
Day move
-2.65%
AIQ Score
54/100
Best edge
Value
Sector
Healthcare

What is the main difference between AXGN and BBNX?

AXGN leads the current stock comparison as AxoGen, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

AxoGen, Inc. vs Beta Bionics, Inc.

Data as of Nov 18, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

AXGN leads

AXGN leads by 11 AIQ points, primarily on Risk Resilience and Quality, and the lead has widened from 0 points over 30 sessions. Wall Street currently favors BBNX on target upside.

Competitive: 4 of 6 evidence groups support AXGN, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Strengthening
AXGN

AxoGen, Inc.

Leads
AIQ Score
65/100
AIQ Edge Score
7/10
BBNX

Beta Bionics, Inc.

AIQ Score
54/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors AXGN over BBNX, 65 versus 54 as of Nov 18, 2026. AXGN's advantage is driven primarily by stronger risk resilience and quality, while BBNX holds the stronger value profile. AXGN also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BBNX. 4 of 6 covered evidence groups favor AXGN today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. AXGN lead: Strengthening — the AIQ differential moved from 0 to 11 points over 30 sessions.

Compare AxoGen, Inc. and Beta Bionics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

AXGN
+211.7%
BBNX
-39.4%

Price return comparison

Growth of $10,000, price only

AXGN $31,171 · BBNX $6,064

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare AXGN and BBNX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AXGN advantage
0
BBNX advantage
  • Risk Resilience55 vs 36
    AXGN +19
  • Quality70 vs 53
    AXGN +17
  • Momentum82 vs 72
    AXGN +10
  • Value33 vs 39
    BBNX +6

4 of 6 evidence groups favor AXGN. AXGN’s edge is concentrated in risk resilience and quality; BBNX keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

AXGN+3 AIQ

Largest factor move: Momentum +8

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.66x)
BBNX+1 AIQ

Largest factor move: Momentum +2

No signal started or stopped since the prior session; its 4 active signals are unchanged.

AXGN's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — AXGN and BBNX both carry a full feed there.

The central trade-off

AXGN (AxoGen, Inc.): the stronger current systematic profile, led by risk resilience and quality.

BBNX (Beta Bionics, Inc.): the counter-case, on value, valuation, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AXGN

AXGN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AXGN

AXGN on combined revenue and EPS growth.

Value

BBNX

BBNX on the peer-relative Value factor, by 6 points.

Momentum

AXGN

AXGN on the Momentum factor, by 10 points.

Lower downside

AXGN

AXGN on Risk Resilience, by 19 points.

Analyst upside

BBNX

BBNX on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors AXGN, analyst targets favor BBNX. That disagreement is the most useful thing on this page.

MeasureAXGNBBNXNote
Implied upside to target+2.1%+71.7%BBNX has more room
Target dispersion+20.6%+56.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1115Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor AXGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreAXGN65 vs 54
FundamentalsAXGNon balancerevenue growth 8.8% vs 10.9%; EPS growth 233.3% vs 1.9%; gross margin 74.2% vs 58.6%; operating margin -5.2% vs -72.7% — AXGN takes 3 of 4 decided legs, not all of them
ValuationBBNXValue 33 vs 39
TechnicalsAXGNPrice vs 50-day 31.6% vs -22.4%; vs 200-day 38% vs 10.8%
Risk ResilienceAXGNRisk Resilience 55 vs 36
Analyst expectationsBBNXTarget upside 2.1% vs 71.7%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AXGN and BBNX and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 11 points.
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AXGN.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

AXGN lead: Strengthening — the AIQ differential moved from 0 to 11 points over 30 sessions.

Jun 1AXGN leads above the line · BBNX leads belowNov 18
Today
AXGN +11
65 vs 54
7 sessions ago
AXGN +7
62 vs 55
30 sessions ago
Level
56 vs 56
90 sessions ago
AXGN +7
64 vs 57

The lead changed hands once in this window, most recently on Nov 4 when AXGN moved ahead of BBNX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AXGNConflicted

5 bullish / 1 bearish / 2 neutral, conflicted

Only AXGN

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.66x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
BBNXConflicted

1 bullish / 1 bearish / 2 neutral, conflicted

Only BBNX

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon

Both carry 2 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode.

AXGN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AXGNConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +2.85%, AIQ +3 points).

BBNXDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.65%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BBNX closes the Risk Resilience gap — currently 19 points behind, the largest single contributor to AXGN's edge.
  2. 2BBNX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3AXGN's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AXGN leads on balance
MetricAXGNBBNX
Revenue growth (YoY)8.8%10.9%
EPS growth (YoY)233.3%1.9%
Gross margin74.2%58.6%
Operating margin-5.2%-72.7%
Return on equity (TTM)0.5%-6.1%
Debt to equity0.040.02

Performance

AXGN leads 5 of 6 windows
MetricAXGNBBNX
1 week (5 sessions)11.8%4.6%
1 month (20 sessions)61.6%0.4%
3 months (63 sessions)13.8%-6.5%
6 months (126 sessions)36.4%73.6%
Year to date70.9%-46.1%
1 year (252 sessions)132.2%-41.7%

Technicals

AXGN has the stronger structure
MetricAXGNBBNX
RSI (14)69.945.5
ADX (14)41.913
Price vs 50-day31.6%-22.4%
Price vs 200-day38%10.8%
Volatility (1M, annualized)125.5%109.6%

Risk

AXGN is the more resilient
MetricAXGNBBNX
Beta1.091.47
Sharpe ratio1.61-0.16
Sortino ratio2.99-0.22
Max drawdown-33.1%-72.3%
Current drawdown-4.6%-48.7%
Annualized volatility61.3%84.7%
Value at risk (95%)-5%-7.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AXGN or BBNX?

On the Algovestiq AIQ Score, AXGN is the stronger of the two as of Nov 18, 2026, scoring 65 against BBNX's 54. The edge comes from risk resilience and quality. BBNX is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AXGN or BBNX the better buy right now?

AXGN carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor AXGN over BBNX?

The composite weights Quality, Value, Momentum and Risk Resilience. AXGN leads Risk Resilience by 19 points; AXGN leads Quality by 17 points; AXGN leads Momentum by 10 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AXGN or BBNX?

Analyst price targets imply +2.1% upside for AXGN and +71.7% for BBNX, so the Street currently favors BBNX. That points the opposite way to the AIQ Score, which favors AXGN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AXGN or BBNX?

BBNX is the better-valued of the two on the peer-relative Value factor. BBNX on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AXGN or BBNX?

AXGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AXGN or BBNX?

AXGN on the Momentum factor, by 10 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AXGN or BBNX?

AXGN is the more resilient of the two, so the other name carries the higher downside risk. AXGN on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AXGN more profitable than BBNX?

AXGN leads on the comparable margin measures — gross margin 74.2% vs 58.6%; operating margin -5.2% vs -72.7%; ttm roe 0.5% vs -6.1%.

Is AXGN's lead over BBNX getting stronger or weaker?

AXGN lead: Strengthening — the AIQ differential moved from 0 to 11 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has changed hands once in that window, most recently on 2026-11-04, when AXGN moved ahead of BBNX.

What would change the AXGN vs BBNX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BBNX closes the Risk Resilience gap — currently 19 points behind, the largest single contributor to AXGN's edge; BBNX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; AXGN's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AXGN and BBNX?

AXGN: 5 bullish / 1 bearish / 2 neutral, conflicted. BBNX: 1 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AXGN is Golden Cross Active (bullish, long horizon). On BBNX it is Golden Cross Active (bullish, long horizon).

Compare AXGN and BBNX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.